Thromboprophylaxis in COVID-19: Still in the fog?
Abstract
Carta al Director de la Revista, comentando aspectos sobre la realidad cínica del manejo de los fenómenos trombóticos asociados a la infección por SARS-CoV-2.Downloads
References
Magro C, Mulvey J, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infec¬tion: A report of five cases. 2020; Transl Res. doi: 10.1016/j. trsl.2020.04.007.
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe co-ronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-1099. https://doi.org/10.1111/ jth.14817.
Driggin E. Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020; 75: 2352–2371.doi: 10.1016/j.jacc.2020.03.031
Hunt B,Retter A, McClintock C. Practical Guidance for the Prevention of Thrombosis and Management of Coagulopathy and Disseminated Intravascular Coagulation of Patients Infected with COVID-19; British Society for Haematology: London, England, 2020.
World Health Organization. Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019- nCoV) Infection Is Suspected: Interim Guidance; WHO/ nCoV/Clinical/2020.3; World Health Organization: Geneva, Switzerland, 2020.
Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020; doi: 10.1016/S2352-3026(20)30109-5.
Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020; 46:1089–1098. doi: 10.1007/s00134-020-06062-x
Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Muller MCA, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 2020;18(8):1995-2002. doi: 10.1111/jth.14888.
Chi, Gerald; Lee, Jane J.; Jamil, Adeel; Gunnam, Vamsikrishna; Najafi, Homa; Montazerin, Sahar Memar; Shojaei, Fahi-mehalsadat; Marszalek, Jolanta. Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: A systematic review and meta-analysis. J Clin Med. 2020; 8(9):1-17. doi:10.3390/jcm9082489.
Mattioli M, Benfaremo D, Mancini M, Mucci L, Mainquà P, Polenta A, et al. Safety of intermediate dose of low molecu¬lar weight heparin in COVID 19 patients. Journal of Thromb Thrombolysis. Published online: 13 August 2020. https://doi. org/10.1007/s11239-020-02243-z
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
